Abstract
The 18th Conference on Retroviruses and Opportunistic Infections maintained its tradition of being the preeminent forum for detailing the state-ofthe- art in antiretroviral therapy. There were important presentations on investigational antiretroviral drugs, clinical trials in treatment-experienced patients, and new antiretroviral strategies. Relevant data on resistance to antiretroviral drugs and pharmacokinetic interactions were discussed. There were extensive presentations on antiretroviral therapy in resourcelimited settings, including large-scale clinical trials, scale-up of antiretroviral therapy, adherence, retention in care, and treatment outcomes for children and adults. Prevention of mother-to-child transmission continued to be an important part of the conference.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 69-97 |
| Number of pages | 29 |
| Journal | Topics in Antiviral Medicine |
| Volume | 19 |
| Issue number | 2 |
| State | Published - May 2011 |
ASJC Scopus subject areas
- General Medicine